The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+26.6% to $278.00
Predicted High$278.00at 6 months
Predicted Low$224.50in 2 weeks
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Sep 18, 2026 1:02 pm
Bull
NVDA trends higher to
$278.00
(+26.6% from $219.67)
by Mar 2027.
dip-then-recover
ThesisNVDA sits well below composite fair value ($337) with strong quality, five straight beats, and a euphoric AI narrative amplified by Huang's 2027 doubling call. High beta and a neutral regime allow near-term chop, but value gravity and momentum should pull the tape higher over six months toward the deterministic $283 baseline.
Invalidated ifA break below $195 on heavy volume or a Huang/guidance walk-back on 2027 doubling claim
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $219.67 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Sep 18, 2026
—
$219.67at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Oct 2, 2026
$202.32–$237.02typical range · internal point $224.50
—
±7.9%
6/10
Narrative momentum and Huang megaphone lift high-beta name
What actually happened:
closed $230.86
on Oct 1, 2026 = +5.1% vs the call
(predicted +2.2%)
· direction MISS
(called flat, was up)
· off by 2.9 pp
· accuracy 4/10
· typical range ±7.9%:
inside the band
· S&P +0.2%
over the same window — beat it
1 month
Oct 18, 2026
$194.53–$244.81typical range · internal point $228.00
—
±11.4%
5/10
Drift higher as AI capex headlines persist
2 months
Nov 18, 2026
$234.00
—
+6.5%
4/10
Consolidation; no catalyst, macro chop weighs
3 months
Dec 18, 2026
$245.00
—
+11.5%
4/10
Year-end positioning into AI winners resumes
4 months
Jan 18, 2027
$258.00
—
+17.5%
4/10
January CES and hyperscaler capex guides support
5 months
Feb 18, 2027
$270.00
—
+22.9%
4/10
Pre-earnings run as 2027 doubling narrative crystallizes
6 months
Mar 18, 2027
$278.00
—
+26.6%
3/10
Value gap closes toward composite fair value anchor
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$283.07
(+28.9%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.